OpenURL Connection Search

Select item for more details and to access through your institution.

Erratum to: Vitamin D Status and Bone Mineral Density Changes During Alendronate Treatment in Postmenopausal Osteoporosis.
Published in:
2014
By:
- Roux, Christian;
- Binkley, Neil;
- Boonen, Steven;
- Kiel, Douglas;
- Ralston, Stuart;
- Reginster, Jean-Yves;
- Pong, Annpey;
- Rosenberg, Elizabeth;
- Santora, Arthur
Publication type:
Correction Notice
Vitamin D Status and Bone Mineral Density Changes During Alendronate Treatment in Postmenopausal Osteoporosis.
Published in:
Calcified Tissue International, 2014, v. 94, n. 2, p. 153, doi. 10.1007/s00223-013-9763-1
By:
- Roux, Christian;
- Binkley, Neil;
- Boonen, Steven;
- Kiel, Douglas;
- Ralston, Stuart;
- Regnister, Jean-Yves;
- Pong, Annpey;
- Rosenberg, Elizabeth;
- Santora, Arthur
Publication type:
Article
Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials.
Published in:
Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0856-7
By:
- Liu, Jie;
- Pong, Annpey;
- Gallo, Silvina;
- Darekar, Amanda;
- Terra, Steven G.
Publication type:
Article
Evaluation of factors contributing to the response to fosaprepitant in a heterogeneous, moderately emetogenic chemotherapy population: an exploratory analysis of a randomized phase III trial.
Published in:
2018
By:
- Weinstein, Cindy;
- Pong, Annpey;
- Jordan, Karin;
- Green, Stuart A.;
- Beckford-Brathwaite, Elizabeth;
- Camacho, Elber;
- Khanani, Saleem;
- Noga, Stephen J.;
- Rapoport, Bernardo L.
Publication type:
journal article
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy regimens: a subgroup analysis from a randomized clinical trial of response in subjects by cancer type.
Published in:
2020
By:
- Weinstein, Cindy;
- Jordan, Karin;
- Green, Stuart;
- Khanani, Saleem;
- Beckford-Brathwaite, Elizabeth;
- Vallejos, Waldimir;
- Pong, Annpey;
- Noga, Stephen J.;
- Rapoport, Bernardo L.
Publication type:
journal article
Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter].
Published in:
2022
By:
- Cherney, David Z. I.;
- Charbonnel, Bernard;
- Cosentino, Francesco;
- Dagogo-Jack, Samuel;
- McGuire, Darren K.;
- Pratley, Richard;
- Shih, Weichung J.;
- Frederich, Robert;
- Maldonado, Mario;
- Pong, Annpey;
- Cannon, Christopher P.
Publication type:
Letter
Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial.
Published in:
Diabetologia, 2021, v. 64, n. 6, p. 1256, doi. 10.1007/s00125-021-05407-5
By:
- Cherney, David Z. I.;
- Charbonnel, Bernard;
- Cosentino, Francesco;
- Dagogo-Jack, Samuel;
- McGuire, Darren K.;
- Pratley, Richard;
- Shih, Weichung J.;
- Frederich, Robert;
- Maldonado, Mario;
- Pong, Annpey;
- Cannon, Christopher P.
Publication type:
Article
Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials.
Published in:
Diabetologia, 2020, v. 63, n. 6, p. 1128, doi. 10.1007/s00125-020-05133-4
By:
- Cherney, David Z. I.;
- Heerspink, Hiddo J. L.;
- Frederich, Robert;
- Maldonado, Mario;
- Liu, Jie;
- Pong, Annpey;
- Xu, Zhi J.;
- Patel, Shrita;
- Hickman, Anne;
- Mancuso, James P.;
- Gantz, Ira;
- Terra, Steven G.
Publication type:
Article
Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium‐glucose cotransporter‐2 inhibitor ertugliflozin
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 758, doi. 10.1111/dom.14923
By:
- Corbin, Karen D.;
- Dagogo‐Jack, Samuel;
- Cannon, Christopher P.;
- Cherney, David Z.I.;
- Cosentino, Francesco;
- Frederich, Robert;
- Liu, Jie;
- Pong, Annpey;
- Lin, Jianxin;
- Cater, Nilo B.;
- Pratley, Richard E.
Publication type:
Article
Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1829, doi. 10.1111/dom.14769
By:
- Segar, Matthew W.;
- Kolkailah, Ahmed A.;
- Frederich, Robert;
- Pong, Annpey;
- Cannon, Christopher P.;
- Cosentino, Francesco;
- Dagogo‐Jack, Samuel;
- McGuire, Darren K.;
- Pratley, Richard E.;
- Liu, Chih‐Chin;
- Maldonado, Mario;
- Liu, Jie;
- Cater, Nilo B.;
- Pandey, Ambarish;
- Cherney, David Z. I.
Publication type:
Article
Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1245, doi. 10.1111/dom.14691
By:
- Dagogo‐Jack, Samuel;
- Cannon, Christopher P.;
- Cherney, David Z. I.;
- Cosentino, Francesco;
- Liu, Jie;
- Pong, Annpey;
- Gantz, Ira;
- Frederich, Robert;
- Mancuso, James P.;
- Pratley, Richard E.
Publication type:
Article
The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CV.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1114, doi. 10.1111/dom.14677
By:
- Cherney, David Z. I.;
- Cosentino, Francesco;
- Pratley, Richard E.;
- Dagogo‐Jack, Samuel;
- Frederich, Robert;
- Maldonado, Mario;
- Liu, Jie;
- Pong, Annpey;
- Liu, Chih‐Chin;
- Cannon, Christopher P.
Publication type:
Article
The effects of ertugliflozin on β‐cell function: Pooled analysis from four phase 3 randomized controlled studies.
Published in:
Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2267, doi. 10.1111/dom.14149
By:
- Gallo, Silvina;
- Raji, Annaswamy;
- Calle, Roberto A.;
- Pong, Annpey;
- Meyer, Christian
Publication type:
Article
Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studies.
Published in:
Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2276, doi. 10.1111/dom.14150
By:
- Pratley, Richard;
- Dagogo‐Jack, Samuel;
- Charbonnel, Bernard;
- Patel, Shrita;
- Hickman, Anne;
- Liu, Jie;
- Tarasenko, Lisa;
- Pong, Annpey;
- Ellison, Misoo C.;
- Huyck, Susan;
- Gantz, Ira;
- Terra, Steven G.
Publication type:
Article
Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus.
Published in:
Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 574, doi. 10.1111/dom.13931
By:
- Liu, Jie;
- Patel, Shrita;
- Cater, Nilo B.;
- Wu, Larry;
- Huyck, Susan;
- Terra, Steven G.;
- Hickman, Anne;
- Darekar, Amanda;
- Pong, Annpey;
- Gantz, Ira
Publication type:
Article
Novel Design and Analysis for Rare Disease Drug Development.
Published in:
Mathematics (2227-7390), 2024, v. 12, n. 5, p. 631, doi. 10.3390/math12050631
By:
- Chow, Shein Chung;
- Pong, Annpey;
- Chow, Susan S.
Publication type:
Article
Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies.
Published in:
Diabetes & Vascular Disease Research, 2019, v. 16, n. 5, p. 415, doi. 10.1177/1479164119842513
By:
- Liu, Jie;
- Tarasenko, Lisa;
- Terra, Steven G;
- Huyck, Susan;
- Wu, Larry;
- Pong, Annpey;
- Calle, Roberto A;
- Gallo, Silvina;
- Darekar, Amanda;
- Mancuso, James P
Publication type:
Article
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in paediatric subjects: An analysis by age group.
Published in:
2018
By:
- Kang, Hyoung Jin;
- Loftus, Susan;
- DiCristina, Cara;
- Green, Stuart;
- Pong, Annpey;
- Zwaan, Christian Michel
Publication type:
journal article
Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials.
Published in:
Diabetes Therapy, 2020, v. 11, n. 8, p. 1849, doi. 10.1007/s13300-020-00867-1
By:
- Gallo, Silvina;
- Calle, Roberto A.;
- Terra, Steven G.;
- Pong, Annpey;
- Tarasenko, Lisa;
- Raji, Annaswamy
Publication type:
Article
Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial.
Published in:
American Journal of Nephrology, 2022, v. 53, n. 7, p. 516, doi. 10.1159/000524889
By:
- Cherney, David Z.I.;
- Cosentino, Francesco;
- Dagogo-Jack, Samuel;
- McGuire, Darren K.;
- Pratley, Richard E.;
- Frederich, Robert;
- Maldonado, Mario;
- Liu, Chih-Chin;
- Pong, Annpey;
- Cannon, Christopher P.
Publication type:
Article
Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus.
Published in:
2020
By:
- Heymsfield, Steven B.;
- Raji, Annaswamy;
- Gallo, Silvina;
- Liu, Jie;
- Pong, Annpey;
- Hannachi, Hakima;
- Terra, Steven G.
Publication type:
journal article
796-P: Cardiorenal Outcomes with Ertugliflozin by Baseline Cardiorenal Medications: An Analysis from VERTIS CV.
Published in:
Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-796-P
By:
- CHERNEY, DAVID;
- COSENTINO, FRANCESCO;
- MCGUIRE, DARREN K.;
- CHARBONNEL, BERNARD;
- DAGOGO-JACK, SAMUEL;
- PRATLEY, RICHARD E.;
- SHIH, WEICHUNG J.;
- MALDONADO, MARIO;
- PONG, ANNPEY;
- GANTZ, IRA;
- FREDERICH, ROBERT;
- MANCUSO, JAMES P.;
- MASIUKIEWICZ, URSZULA;
- CANNON, CHRISTOPHER P.
Publication type:
Article
783-P: Cardiorenal Outcomes with Ertugliflozin by Baseline (BL) Glucose-Lowering Agent (GLA): An Analysis from VERTIS CV.
Published in:
Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-783-P
By:
- CHARBONNEL, BERNARD;
- DAGOGO-JACK, SAMUEL;
- CANNON, CHRISTOPHER P.;
- CHERNEY, DAVID;
- COSENTINO, FRANCESCO;
- MCGUIRE, DARREN K.;
- SHIH, WEICHUNG J.;
- LIU, JIE;
- PONG, ANNPEY;
- GANTZ, IRA;
- FREDERICH, ROBERT;
- MANCUSO, JAMES P.;
- PRATLEY, RICHARD E.
Publication type:
Article
1197-P: Two-Year Effects of Ertugliflozin on Renal Function.
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1197-P
By:
- CHERNEY, DAVID;
- HEERSPINK, HIDDO L.;
- FREDERICH, ROBERT;
- MALDONADO, MARIO;
- PONG, ANNPEY;
- XU, ZHI JIN;
- LIU, JIE;
- MANCUSO, JAMES P.;
- GANTZ, IRA;
- TERRA, STEVEN G.
Publication type:
Article
1188-P: Glycemic Efficacy of Sitagliptin in East Asian Populations: A Pooled Analysis.
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1188-P
By:
- CONCEICAO, JOAO M.;
- GONZALEZ, CLAUDIO D.;
- ENGEL, SAMUEL S.;
- AHN, JONGHO;
- TOKITA, SHIGERU;
- ZHANG, YE;
- ZHANG, RUYA;
- LAM, RAYMOND L.;
- PONG, ANNPEY
Publication type:
Article
1153-P: Changes Observed during the Screening Period in Patients Enrolled in the Sitagliptin Clinical Study MK-0431-P083.
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1153-P
By:
- ROSARIO, CARMEN A.;
- JALALUDIN, MUHAMMAD Y.;
- GARCIA, RAYMUNDO;
- NEWFIELD, RON S.;
- SAMOILOVA, YULIA;
- SHEHADEH, NAIM;
- PONG, ANNPEY;
- ZILLI, MARTINA;
- SAHA, CHANDAN K.;
- ENGEL, SAMUEL S.;
- ZEITLER, PHILIP;
- KAUFMAN, KEITH D.;
- SHANKAR, R. RAVI
Publication type:
Article
2353-PUB: Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM).
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2353-PUB
By:
- LIU, JIE;
- TARASENKO, LISA;
- ELLISON, MISOO C.;
- PONG, ANNPEY;
- HUYCK, SUSAN;
- MANCUSO, JAMES P.;
- TERRA, STEVEN G.;
- GANTZ, IRA
Publication type:
Article

Found: 27